These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31104218)

  • 41. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.
    Zhou T; Guan H; Yao J; Xiong X; Ma A
    Qual Life Res; 2018 Nov; 27(11):2799-2814. PubMed ID: 29980994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Choice Defines QALYs: A US Valuation of the EQ-5D-5L.
    Craig BM; Rand K
    Med Care; 2018 Jun; 56(6):529-536. PubMed ID: 29668646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population.
    Gandhi M; Thumboo J; Luo N; Wee HL; Cheung YB
    Health Qual Life Outcomes; 2015 Jan; 13():8. PubMed ID: 25617062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Valuation of the EQ-5D-3L in Russia.
    Omelyanovskiy V; Musina N; Ratushnyak S; Bezdenezhnykh T; Fediaeva V; Roudijk B; Purba FD
    Qual Life Res; 2021 Jul; 30(7):1997-2007. PubMed ID: 33713323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country.
    Senanayake S; Mahesh PKB; Gunawardena N; Graves N; Kularatna S
    PLoS One; 2019; 14(6):e0211604. PubMed ID: 31242189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study.
    Takemoto ML; Lopes da Silva N; Ribeiro-Pereira AC; Schilithz AO; Suzuki C
    Health Qual Life Outcomes; 2015 Aug; 13():119. PubMed ID: 26246238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
    Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
    BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population.
    Nemes S; Burström K; Zethraeus N; Eneqvist T; Garellick G; Rolfson O
    Qual Life Res; 2015 Dec; 24(12):2963-70. PubMed ID: 26038221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries.
    Janssen MF; Szende A; Cabases J; Ramos-Goñi JM; Vilagut G; König HH
    Eur J Health Econ; 2019 Mar; 20(2):205-216. PubMed ID: 29445941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catalog of EQ-5D-3L Health-Related Quality-of-Life Scores for 199 Chronic Conditions and Health Risks in Denmark.
    Hvidberg MF; Petersen KD; Davidsen M; Witt Udsen F; Frølich A; Ehlers L; Alava MH
    MDM Policy Pract; 2023; 8(1):23814683231159023. PubMed ID: 37056295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
    Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
    Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment.
    Shafie AA; Chhabra IK; Wong JHY; Mohammed NS
    Health Qual Life Outcomes; 2021 Jan; 19(1):10. PubMed ID: 33413416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.
    Zrubka Z; Rencz F; Závada J; Golicki D; Rupel VP; Simon J; Brodszky V; Baji P; Petrova G; Rotar A; Gulácsi L; Péntek M
    Rheumatol Int; 2017 Dec; 37(12):1957-1977. PubMed ID: 28849432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).
    Thuppal S; Markwell S; Crabtree T; Hazelrigg S
    Qual Life Res; 2019 Jul; 28(7):1885-1892. PubMed ID: 30707368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
    Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
    Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
    Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
    Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review.
    Prevolnik Rupel V; Divjak M; Zrubka Z; Rencz F; Gulácsi L; Golicki D; Mirowska-Guzel D; Simon J; Brodszky V; Baji P; Závada J; Petrova G; Rotar A; Péntek M
    Eur J Health Econ; 2019 Jun; 20(Suppl 1):109-117. PubMed ID: 31098882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.